BupsA.00130.a
peptidyl-prolyl cis-trans isomerase
CENTER ID:
BupsA.00130.a
ORGANISM:
Burkholderia pseudomallei 1710b
ASSOCIATED DISEASE:
Melioidosis
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
3
SELECT AGENT:
True
NIH PRIORITY
pathogens category:
IIIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
BupsA.00130.a.A1.GE25240
Full length( BupsA.00130.a )
info
1
113
BupsA.00130.a.A1.GE25240
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
BupsA.00130.a.D228.PD00185
full length
info
2
113
PD00185
BupsA.00130.a.D214.PD00190
full length
info
2
113
PD00190
BupsA.00130.a.D219.PD00191
full length
info
2
113
PD00191
BupsA.00130.a.D227.PD00193
full length
info
2
113
PD00193
BupsA.00130.a.D24.PD00194
full length
info
2
113
PD00194
BupsA.00130.a.D212.PD00195
full length
info
2
113
PD00195
BupsA.00130.a.D242.PD00198
full length
info
2
113
PD00198
BupsA.00130.a.D243.PD00199
full length
info
2
113
PD00199
BupsA.00130.a.D248.PD00210
full length
info
2
113
PD00210
BupsA.00130.a.D237.PD00212
full length
info
2
113
PD00212
BupsA.00130.a.D240.PD00213
full length
info
2
113
PD00213
BupsA.00130.a.A1.PS01414
Full length( BupsA.00130.a )
info
1
113
PS01414
BupsA.00130.a.A1.PS01451
Full length( BupsA.00130.a )
info
1
113
PS01451
Structures
2KE0
DEPOSITED: 1/21/2009
DETERMINATION: NMR
CLONE: BupsA.00130.a.A1.GE25240
PROTEIN: BupsA.00130.a.A1.PW25599
2KO7
DEPOSITED: 9/11/2009
DETERMINATION: NMR
CLONE: BupsA.00130.a.A1.GE25240
PROTEIN: BupsA.00130.a.A1.PW25599
2L2S
DEPOSITED: 8/27/2010
DETERMINATION: NMR
CLONE: BupsA.00130.a.A1.GE25240
PROTEIN: BupsA.00130.a.A1.PW25599
3UF8
DEPOSITED: 10/31/2011
DETERMINATION: XRay
CLONE: BupsA.00130.a.D242.GE00001
PROTEIN: BupsA.00130.a.D242.PD00198
3UQB
DEPOSITED: 11/19/2011
DETERMINATION: XRay
CLONE: BupsA.00130.a.D214.GE00001
PROTEIN: BupsA.00130.a.D214.PD00190
3UQA
DEPOSITED: 11/19/2011
DETERMINATION: XRay
CLONE: BupsA.00130.a.D220.GE00001
PROTEIN: BupsA.00130.a.D220.PD00197
3VAW
DEPOSITED: 12/29/2011
DETERMINATION: XRay
CLONE: BupsA.00130.a.D24.GE00001
PROTEIN: BupsA.00130.a.D24.PD00194
4DZ3
DEPOSITED: 2/29/2012
DETERMINATION: XRay
CLONE:
PROTEIN: BupsA.00130.a.D227.PD00193
4DZ2
DEPOSITED: 2/29/2012
DETERMINATION: XRay
CLONE: BupsA.00130.a.D239.GE00001
PROTEIN: BupsA.00130.a.D239.PD00214
4FN2
DEPOSITED: 6/19/2012
DETERMINATION: XRay
CLONE: BupsA.00130.a.D214.GE00001
PROTEIN: BupsA.00130.a.D214.PD00196
4G50
DEPOSITED: 7/17/2012
DETERMINATION: XRay
CLONE: BupsA.00130.a.D214.GE00001
PROTEIN: BupsA.00130.a.D214.PD00196
4GGQ
DEPOSITED: 8/7/2012
DETERMINATION: XRay
CLONE: BupsA.00130.a.D21.GE00001
PROTEIN: BupsA.00130.a.D21.PD00188
4GIV
DEPOSITED: 8/9/2012
DETERMINATION: XRay
CLONE: BupsA.00130.a.D214.GE00001
PROTEIN: BupsA.00130.a.D214.PD00196
6O4A
DEPOSITED: 2/28/2019
DETERMINATION: XRay
CLONE: BupsA.00130.a.D21.GE00001
PROTEIN: BupsA.00130.a.D21.PD00188
6O49
DEPOSITED: 2/28/2019
DETERMINATION: XRay
CLONE: BupsA.00130.a.D21.GE00001
PROTEIN: BupsA.00130.a.D21.PD00188
Publications by SSGCID
The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development.
Harmer NJ, Norville IH, O'Shea K, Sarkar-Tyson M, Titball RW, Varani G, Zheng S
Biochem. J. - 2011
volume 437, issue 3, pages 413-22
A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.
Abendroth J, Anderson V, Atkins K, Barnes SR, Begley DW, Edwards TE, Fox D, Harmer NJ, Holzgrabe U, Jenner D, Juli C, Lorimer DD, Moen SO, Muruthi M, Myler PJ, Norville IH, Pierce PG, Raymond AC, Safford K, Sarkar-Tyson M, Stacy R, Staker BL
Antimicrob. Agents Chemother. - 2013
volume 58, issue 3, pages 1458-67
Broad-spectrum Activity of Macrophage Infectivity Potentiator Inhibitors Against Gram-negative Bacteria and Leishmania major
Harmer NJ, Holzgrabe U, Lorimer DD, Myler PJ, Norville IH, Sarkar-Tyson M, Iwasaki J, Kibble EA, Bzdyl N, Kristensen S, Seufert F, Schmitz J, lewis m
J. Antimicrob. Chemother. - 2022
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MTVVTTESGL KYEDLTEGSG AEARAGQTVS VHYTGWLTDG QKFDSSKDRN DPFAFVLGGG MVIKGWDEGV QGMKVGGVRR LTIPPQLGYG ARGAGGVIPP NATLVFEVEL LDV
NT Sequence
ATGACAGTCG TCACCACCGA ATCGGGCCTC AAATACGAAG ACCTGACCGA AGGCTCGGGC GCCGAGGCGC GCGCGGGCCA GACGGTGAGC GTGCACTACA CGGGCTGGCT CACCGACGGC CAGAAGTTCG ATTCGAGCAA GGATCGCAAT GATCCGTTCG CGTTCGTGCT CGGCGGCGGC ATGGTCATCA AGGGGTGGGA CGAAGGCGTG CAAGGGATGA AGGTGGGCGG CGTGCGCCGT CTGACGATCC CGCCGCAACT CGGCTACGGC GCGCGCGGCG CGGGCGGCGT GATTCCGCCC AATGCGACGC TCGTGTTCGA AGTCGAACTG CTCGACGTC
Details for BupsA.00130.a.A1.GE25240
HARVESTED ON:
5/6/2008
SEQUENCED ON:
2/9/2011
EXPECTED MW:
14kDa
OBSERVED MW:
18kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
pass
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98
Details for BupsA.00130.a.D228.PD00185
PURIFICATION DATe:
1/21/2011
CONCENTRATION:
25.47mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
6
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D214.PD00190
PURIFICATION DATe:
2/8/2011
CONCENTRATION:
23.7mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
2
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D219.PD00191
PURIFICATION DATe:
2/8/2011
CONCENTRATION:
28.07mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
1
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D227.PD00193
PURIFICATION DATe:
2/8/2011
CONCENTRATION:
25.22mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
1
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D24.PD00194
PURIFICATION DATe:
2/27/2011
CONCENTRATION:
19.6mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
5
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D212.PD00195
PURIFICATION DATe:
2/27/2011
CONCENTRATION:
21.02mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
5
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D242.PD00198
PURIFICATION DATe:
2/27/2011
CONCENTRATION:
21.4mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
4
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D243.PD00199
PURIFICATION DATe:
2/27/2011
CONCENTRATION:
19.3mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
3
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D248.PD00210
PURIFICATION DATe:
6/10/2011
CONCENTRATION:
21.02mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
4
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D237.PD00212
PURIFICATION DATe:
6/10/2011
CONCENTRATION:
19.95mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
1
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.D240.PD00213
PURIFICATION DATe:
6/10/2011
CONCENTRATION:
5.47mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris-HCl, pH 8.0, 200mM NaCl, 1% glycerol, 1mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
7
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for BupsA.00130.a.A1.PS01414
PURIFICATION DATe:
3/7/2012
CONCENTRATION:
80.18mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
7
VIAL VOLUME:
110µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98
Details for BupsA.00130.a.A1.PS01451
PURIFICATION DATe:
4/3/2012
CONCENTRATION:
60.1mg/ml
OBSERVED MW:
data unavailable
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
8
VIAL VOLUME:
110µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98